Galena Biopharma (GALE) Reports Q3 Loss of $0.13
Tweet
Share
E-mailGet Alerts GALE Hot Sheet
Join SI Premium – FREE
Galena Biopharma (NASDAQ: GALE) reported Q3 EPS of ($0.13), versus ($0.16) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Cal-Maine Foods (CALM) Misses Q1 EPS by 79c
- Yiren Digital Ltd. (YRD) Reports Q2 Loss of RMB5.11
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
